{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T10:08:49Z","timestamp":1782382129325,"version":"3.54.5"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","award":["ASPIRE21\/67169339"],"award-info":[{"award-number":["ASPIRE21\/67169339"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI23_01288"],"award-info":[{"award-number":["PI23_01288"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Variant transthyretin (ATTRv) amyloidosis is a rare, inherited disorder caused by mutations in the <jats:italic>TTR<\/jats:italic> gene, leading to amyloid fibril deposition. The Balearic Islands are a known endemic focus for the NP_000362.1:p.Val50Met (V30M) variant, one of the most prevalent pathogenic mutations. We analysed 23 years of genetic testing data from the Balearic Islands\u2019 public health system to determine the prevalence and distribution of ATTR pathogenic variants, with a focus on V30M. A total of 1,478 individuals underwent genetic testing, with 319 positive tests for ATTRv: 308 carried the V30M variant (96.4%) and 11 carried other pathogenic variants. The V30M prevalence was highest in Mallorca and Menorca (1 in 2,900 and 4,700, respectively), with lower rates in Ibiza and Formentera. The co-occurrence of V30M and NP_000362.1:p.Gly26Ser (G6S) on the same chromosome in 93% of V30M carriers suggests a common origin. This study becomes the first registry of ATTRv in the Balearic Islands, aiming to raise awareness among clinicians across all areas and services while enabling more accurate diagnostics, informed genetic counselling, and targeted clinical follow-ups. We also postulate the Balearic Islands as a major global focus for the V30M variant, with a distinct genetic profile suggesting a unique founder effect within the region.<\/jats:p>","DOI":"10.1038\/s41598-025-14707-4","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:19:38Z","timestamp":1755130778000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Genetic testing and evidence of a founder mutation in a hotspot for hereditary transthyretin amyloidosis"],"prefix":"10.1038","volume":"15","author":[{"given":"Marc","family":"Ventayol-Guirado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Cisneros-Barroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonia","family":"Ribot-Sanso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Gonzalez-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Losada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Ripoll-Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Pons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Fortuny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Figuerola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Descals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan Carles","family":"Montala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Alvarez-Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Hernandez-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Lustre-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Victoria","family":"Llull-Alberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Antonio","family":"Jimenez-Barcelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Jose","family":"Asensio-Landa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Torres-Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iciar","family":"Martinez-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Buades-Reines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Heine-Su\u00f1er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"14707_CR1","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/brain\/75.3.408","volume":"75","author":"C Andrade","year":"1952","unstructured":"Andrade, C. A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 75, 408\u2013427 (1952).","journal-title":"Brain"},{"key":"14707_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1046\/j.1365-2141.2001.02999.x","volume":"114","author":"RA Kyle","year":"2001","unstructured":"Kyle, R. A. Amyloidosis: a convoluted story. Br. J. Haematol. 114, 529\u2013538 (2001).","journal-title":"Br. J. Haematol."},{"key":"14707_CR3","doi-asserted-by":"publisher","DOI":"10.5772\/INTECHOPEN.97826","author":"JS Harrison","year":"2021","unstructured":"Harrison, J. S. et al. An historical overview of the amyloidoses. Amyloidosis - Hist. Perspect. https:\/\/doi.org\/10.5772\/INTECHOPEN.97826 (2021).","journal-title":"Amyloidosis - Hist. Perspect."},{"key":"14707_CR4","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.1073\/pnas.75.9.4499","volume":"75","author":"PP Costa","year":"1978","unstructured":"Costa, P. P., Figueira, A. S. & Bravo, F. R. Amyloid fibril protein related to prealbumin in Familial amyloidotic polyneuropathy. Proc. Natl. Acad. Sci. 75, 4499\u20134503 (1978).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"14707_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/0006-291X(83)90831-8","volume":"114","author":"FE Dwulet","year":"1983","unstructured":"Dwulet, F. E. & Benson, M. D. Polymorphism of human plasma thyroxine binding prealbumin. Biochem. Biophys. Res. Commun. 114, 657\u2013662 (1983).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"14707_CR6","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S0006-291X(83)80224-1","volume":"116","author":"S Tawara","year":"1983","unstructured":"Tawara, S., Nakazato, M., Kangawa, K., Matsuo, H. & Araki, S. Identification of amyloid prealbumin variant in Familial amyloidotic polyneuropathy (Japanese type). Biochem. Biophys. Res. Commun. 116, 880\u2013888 (1983).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"14707_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1749-6632.1984.tb13742.x","volume":"435","author":"MJS Mascarenhas","year":"1984","unstructured":"Mascarenhas, M. J. S., Birken, S., Costa, P. P. & Goodman, D. W. Family studies of the genetic abnormality in transthyretin (Prealbumin) in Portuguese patients with Familial amyloidotic Poly neuropathya. Ann. N Y Acad. Sci. 435, 86\u2013100 (1984).","journal-title":"Ann. N Y Acad. Sci."},{"key":"14707_CR8","first-page":"411","volume":"2","author":"AS Whitehead","year":"1984","unstructured":"Whitehead, A. S. et al. Cloning of human prealbumin complementary DNA. Localization of the gene to chromosome 18 and detection of a variant prealbumin allele in a family with Familial amyloid polyneuropathy. Mol. Biol. Med. 2, 411\u2013423 (1984).","journal-title":"Mol. Biol. Med."},{"key":"14707_CR9","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/0006-291X(85)91956-4","volume":"129","author":"MR Wallace","year":"1985","unstructured":"Wallace, M. R. et al. Localization of the human prealbumin gene to chromosome 18. Biochem. Biophys. Res. Commun. 129, 753\u2013758 (1985).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"14707_CR10","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/j.1469-1809.2008.00439.x","volume":"72","author":"C Zaros","year":"2008","unstructured":"Zaros, C. et al. On the origin of the transthyretin Val30Met Familial amyloid polyneuropathy. Ann. Hum. Genet. 72, 478\u2013484 (2008).","journal-title":"Ann. Hum. Genet."},{"key":"14707_CR11","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ajmg.1320600606","volume":"60","author":"A Sousa","year":"1995","unstructured":"Sousa, A., Coelho, T., Barros, J. & Sequeiros, J. Genetic epidemiology of Familial amyloidotic polyneuropathy (FAP)-type I in P\u00f3voa do Varzim and Vila do Conde (north of Portugal). Am. J. Med. Genet. 60, 512\u2013521 (1995).","journal-title":"Am. J. Med. Genet."},{"key":"14707_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.0954-6820.1970.tb08009.x","volume":"1\u20132","author":"R Andersson","year":"1970","unstructured":"Andersson, R. Hereditary amyloidosis with polyneuropathy. Acta Med. Scand. 1\u20132, 85\u201394 (1970).","journal-title":"Acta Med. Scand."},{"key":"14707_CR13","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/archneur.1968.00470360015001","volume":"18","author":"S Araki","year":"1968","unstructured":"Araki, S., Mawatari, S., Ohta, M., Nakajima, A. & Kuroiwa, Y. Polyneuritic amyloidosis in a Japanese family. Arch. Neurol. 18, 593\u2013602 (1968).","journal-title":"Arch. Neurol."},{"key":"14707_CR14","first-page":"441","volume":"91","author":"M Munar-Qu\u00e9s","year":"1988","unstructured":"Munar-Qu\u00e9s, M., Costa, P. P., Saraiva, M. J., Viader-Farr\u00e9, C. & Munar-Bernat, C. Familial type I (Portuguese form) [spanish]myloidotic [spanish]olyneuropathy [spanish]n majorca. [spanish]tudy using the TTR (Met30) genetic marker [Spanish]. Med. Clin. (Barc). 91, 441\u2013444 (1988).","journal-title":"Med. Clin. (Barc)"},{"key":"14707_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.medcli.2016.09.044","volume":"148","author":"M Raya-Cruz","year":"2017","unstructured":"Raya-Cruz, M. et al. Diagn\u00f3stico Precoz En Pacientes Con polineuropat\u00eda amiloid\u00f3tica familiar asociada a transtirretina. Estudio comparativo. Med. Clin. (Barc). 148, 63\u201366 (2017).","journal-title":"Med. Clin. (Barc)"},{"key":"14707_CR16","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/jns.12180","volume":"21","author":"J Buades-Rein\u00e9s","year":"2016","unstructured":"Buades-Rein\u00e9s, J. et al. Transthyretin Familial amyloid polyneuropathy (TTR-FAP) in mallorca: a comparison between late- and early-onset disease. J. Peripher Nerv. Syst. 21, 352\u2013356 (2016).","journal-title":"J. Peripher Nerv. Syst."},{"key":"14707_CR17","doi-asserted-by":"publisher","unstructured":"Cisneros-Barroso, E. et al. Anticipation on age at onset in kindreds with hereditary ATTRV30M amyloidosis from the Majorcan cluster. Amyloid 254\u2013258. https:\/\/doi.org\/10.1080\/13506129.2020.1789580 (2020).","DOI":"10.1080\/13506129.2020.1789580"},{"key":"14707_CR18","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s40120-021-00267-y","volume":"10","author":"J Gonz\u00e1lez-Moreno","year":"2021","unstructured":"Gonz\u00e1lez-Moreno, J. et al. A descriptive analysis of ATTR amyloidosis in Spain from the transthyretin amyloidosis outcomes survey. Neurol. Ther. 10, 833\u2013845 (2021).","journal-title":"Neurol. Ther."},{"key":"14707_CR19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/13506129.2022.2142110","volume":"30","author":"F de Frutos","year":"2023","unstructured":"de Frutos, F. et al. Phenotype and clinical outcomes of Glu89Lys hereditary transthyretin amyloidosis: a new endemic variant in Spain. Amyloid 30, 199\u2013207 (2023).","journal-title":"Amyloid"},{"key":"14707_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1172-8-31","volume":"8","author":"Y Ando","year":"2013","unstructured":"Ando, Y. et al. Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet J. Rare Dis. 8, 31 (2013).","journal-title":"Orphanet J. Rare Dis."},{"key":"14707_CR21","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S1474-4422(23)00334-4","volume":"22","author":"D Adams","year":"2023","unstructured":"Adams, D. et al. Hereditary transthyretin amyloid neuropathies: advances in pathophysiology, biomarkers, and treatment. Lancet Neurol. 22, 1061\u20131074 (2023).","journal-title":"Lancet Neurol."},{"key":"14707_CR22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41582-019-0210-4","volume":"15","author":"D Adams","year":"2019","unstructured":"Adams, D., Koike, H., Slama, M. & Coelho, T. Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease. Nat. Rev. Neurol. 15, 387\u2013404 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"14707_CR23","unstructured":"Rowczenio, D. & Wechalekar, A. Mutations in Hereditary Amyloidosis. (2015). http:\/\/amyloidosismutations.com\/mut-attr.php"},{"key":"14707_CR24","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1001\/jama.2024.0442","volume":"331","author":"FL Ruberg","year":"2024","unstructured":"Ruberg, F. L. & Maurer, M. S. Cardiac amyloidosis due to transthyretin protein: A review. JAMA 331, 778\u2013791 (2024).","journal-title":"JAMA"},{"key":"14707_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2047-9158-3-19","volume":"3","author":"M Ueda","year":"2014","unstructured":"Ueda, M. & Ando, Y. Recent advances in transthyretin amyloidosis therapy. Transl Neurodegener. 3, 1\u201310 (2014).","journal-title":"Transl Neurodegener"},{"key":"14707_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1529-8027.2011.00331.x","volume":"16","author":"M Cappellari","year":"2011","unstructured":"Cappellari, M. et al. Variable presentations of TTR-related Familial amyloid polyneuropathy in seventeen patients. J. Peripher Nerv. Syst. 16, 119\u2013129 (2011).","journal-title":"J. Peripher Nerv. Syst."},{"key":"14707_CR27","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1212\/01.wnl.0000267338.45673.f4","volume":"69","author":"V Plant\u00e9-Bordeneuve","year":"2007","unstructured":"Plant\u00e9-Bordeneuve, V. et al. Diagnostic pitfalls in sporadic transthyretin Familial amyloid polyneuropathy (TTR-FAP). Neurology 69, 693\u2013698 (2007).","journal-title":"Neurology"},{"key":"14707_CR28","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1007\/s00415-013-7124-7","volume":"260","author":"MF Dohrn","year":"2013","unstructured":"Dohrn, M. F. et al. Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy. J. Neurol. 260, 3093\u20133108 (2013).","journal-title":"J. Neurol."},{"issue":"Suppl 1","key":"14707_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3109\/13506129.2012.685665","volume":"19","author":"D Adams","year":"2012","unstructured":"Adams, D. et al. Regional difference and similarity of Familial amyloidosis with polyneuropathy in France. Amyloid 19 (Suppl 1), 61\u201364 (2012).","journal-title":"Amyloid"},{"key":"14707_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3109\/13506129.2011.565524","volume":"18","author":"H Koike","year":"2011","unstructured":"Koike, H. et al. Diagnosis of sporadic transthyretin Val30Met Familial amyloid polyneuropathy: a practical analysis. Amyloid 18, 53\u201362 (2011).","journal-title":"Amyloid"},{"issue":"Suppl 1","key":"14707_CR31","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/WCO.0000000000000288","volume":"29","author":"Y Parman","year":"2016","unstructured":"Parman, Y. et al. Sixty years of transthyretin Familial amyloid polyneuropathy (TTR-FAP) in europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP. Curr. Opin. Neurol. 29 (Suppl 1), S3\u2013S11 (2016).","journal-title":"Curr. Opin. Neurol."},{"key":"14707_CR32","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","volume":"10","author":"V Plant\u00e9-Bordeneuve","year":"2011","unstructured":"Plant\u00e9-Bordeneuve, V. & Said, G. Familial amyloid polyneuropathy. Lancet Neurol. 10, 1086\u20131097 (2011).","journal-title":"Lancet Neurol."},{"issue":"Suppl 1","key":"14707_CR33","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1097\/WCO.0000000000000290","volume":"29","author":"L Obici","year":"2016","unstructured":"Obici, L. et al. Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis. Curr. Opin. Neurol. 29 (Suppl 1), S27\u2013S35 (2016).","journal-title":"Curr. Opin. Neurol."},{"key":"14707_CR34","doi-asserted-by":"crossref","unstructured":"Grandis, M. et al. Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: a multicenter Italian consensus. Orphanet J. Rare Dis 15, (2020).","DOI":"10.1186\/s13023-020-01633-z"},{"key":"14707_CR35","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","volume":"14","author":"H Thorvaldsd\u00f3ttir","year":"2013","unstructured":"Thorvaldsd\u00f3ttir, H., Robinson, J. T. & Mesirov, J. P. Integrative genomics viewer (IGV): high-performance genomics data visualization and exploration. Brief. Bioinform. 14, 178 (2013).","journal-title":"Brief. Bioinform"},{"key":"14707_CR36","unstructured":"Instituto Nacional de Estad\u00edstica. Poblaci\u00f3n por municipios y sexo: Illes Balears. (2023). https:\/\/www.ine.es\/jaxiT3\/Tabla.htm?t=2860&L=0"},{"key":"14707_CR37","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/mus.21028","volume":"37","author":"K Tojo","year":"2008","unstructured":"Tojo, K. et al. Amyloidogenic transthyretin Val30Met homozygote showing unusually early-onset Familial amyloid polyneuropathy. Muscle Nerve. 37, 796\u2013803 (2008).","journal-title":"Muscle Nerve"},{"key":"14707_CR38","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1080\/13506120500032741","volume":"12","author":"M Munar-Qu\u00e9s","year":"2005","unstructured":"Munar-Qu\u00e9s, M. et al. Genetic epidemiology of Familial amyloid polyneuropathy in the Balearic Islands (Spain). Amyloid 12, 54\u201361 (2005).","journal-title":"Amyloid"},{"key":"14707_CR39","unstructured":"GnomAD. GnomAD TTR gene (transthyretin). (2024). https:\/\/gnomad.broadinstitute.org\/gene\/ENSG00000118271?dataset=gnomad_r4"},{"key":"14707_CR40","unstructured":"ClinVar (NCBI). ClinVar - NM_00371.4(TTR):c.76G\u2009>\u2009A (p.Gly26Ser). https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/variation\/13452\/"},{"key":"14707_CR41","unstructured":"ClinVar, N. C. B. I. ClinVar - NM_00371.4(TTR):c.148G\u2009>\u2009A (p.Val50Met). https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/variation\/13417\/?oq=ttr+Val50Met&m=NM_000371.4(TTR):c.148G%3EA (p.Val50Met)."},{"key":"14707_CR42","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s10741-021-10080-2","volume":"27","author":"JN Nativi-Nicolau","year":"2021","unstructured":"Nativi-Nicolau, J. N., Karam, C., Khella, S. & Maurer, M. S. Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness. Heart Fail. Rev. 27, 785 (2021).","journal-title":"Heart Fail. Rev."},{"key":"14707_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/13506129.2018.1556156","volume":"26","author":"I Concei\u00e7\u00e3o","year":"2019","unstructured":"Concei\u00e7\u00e3o, I. et al. Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations*. Amyloid 26, 3\u20139 (2019).","journal-title":"Amyloid"},{"key":"14707_CR44","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cell.2005.01.018","volume":"121","author":"Y Sekijima","year":"2005","unstructured":"Sekijima, Y. et al. The biological and chemical basis for Tissue-Selective amyloid disease. Cell 121, 73\u201385 (2005).","journal-title":"Cell"},{"key":"14707_CR45","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1001\/jamacardio.2020.5969","volume":"6","author":"AM Greve","year":"2021","unstructured":"Greve, A. M., Christoffersen, M., Frikke-Schmidt, R. & Nordestgaard, B. G. Tybj\u00e6rg-Hansen, A. Association of low plasma transthyretin concentration with risk of heart failure in the general population. JAMA Cardiol. 6, 258\u2013266 (2021).","journal-title":"JAMA Cardiol."},{"key":"14707_CR46","doi-asserted-by":"crossref","unstructured":"Bhatt, K. et al. Hereditary transthyretin amyloidosis in patients referred to a genetic testing program. J Am. Heart Assoc 13, (2024).","DOI":"10.1161\/JAHA.123.033770"},{"key":"14707_CR47","doi-asserted-by":"publisher","DOI":"10.1001\/JAMACARDIO.2024.2190","author":"N Aung","year":"2024","unstructured":"Aung, N. et al. Cardiac phenotype, and outcomes of transthyretin variants in the UK biobank population. JAMA Cardiol. https:\/\/doi.org\/10.1001\/JAMACARDIO.2024.2190 (2024). Prevalence.","journal-title":"JAMA Cardiol."},{"key":"14707_CR48","doi-asserted-by":"publisher","first-page":"e000298","DOI":"10.1136\/bmjgh-2017-000298","volume":"2","author":"SH Bots","year":"2017","unstructured":"Bots, S. H., Peters, S. A. E. & Woodward, M. Sex differences in coronary heart disease and stroke mortality: a global assessment of the effect of ageing between 1980 and 2010. BMJ Glob Heal. 2, e000298 (2017).","journal-title":"BMJ Glob Heal"},{"key":"14707_CR49","doi-asserted-by":"publisher","first-page":"E000067","DOI":"10.1161\/HCG.0000000000000067","volume":"13","author":"K Musunuru","year":"2020","unstructured":"Musunuru, K. et al. Genetic testing for inherited cardiovascular diseases: A scientific statement from the American heart association. Circ. Genomic Precis Med. 13, E000067 (2020).","journal-title":"Circ. Genomic Precis Med."},{"key":"14707_CR50","doi-asserted-by":"publisher","first-page":"10","DOI":"10.15420\/ecr.2016:32:1","volume":"12","author":"T Keteepe-Arachi","year":"2017","unstructured":"Keteepe-Arachi, T. & Sharma, S. Cardiovascular disease in women: Understanding symptoms and risk factors. Eur. Cardiol. Rev. 12, 10 (2017).","journal-title":"Eur. Cardiol. Rev."},{"key":"14707_CR51","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/sjop.12545","volume":"60","author":"B Clar\u00e9us","year":"2019","unstructured":"Clar\u00e9us, B. & Renstr\u00f6m, E. A. Physicians\u2019 gender bias in the diagnostic assessment of medically unexplained symptoms and its effect on patient\u2013physician relations. Scand. J. Psychol. 60, 338\u2013347 (2019).","journal-title":"Scand. J. Psychol."},{"key":"14707_CR52","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1212\/WNL.0000000000003293","volume":"87","author":"R Hanewinckel","year":"2016","unstructured":"Hanewinckel, R. et al. Prevalence of polyneuropathy in the general middle-aged and elderly population. Neurology 87, 1892\u20131898 (2016).","journal-title":"Neurology"},{"key":"14707_CR53","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1007\/s00415-018-9123-1","volume":"266","author":"T Julian","year":"2019","unstructured":"Julian, T., Glascow, N., Syeed, R. & Zis, P. Alcohol-related peripheral neuropathy: a systematic review and meta-analysis. J. Neurol. 266, 2907\u20132919 (2019).","journal-title":"J. Neurol."},{"key":"14707_CR54","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10654-015-0094-6","volume":"31","author":"R Hanewinckel","year":"2016","unstructured":"Hanewinckel, R., van Oijen, M., Ikram, M. A. & van Doorn, P. A. The epidemiology and risk factors of chronic polyneuropathy. Eur. J. Epidemiol. 31, 5\u201320 (2016).","journal-title":"Eur. J. Epidemiol."},{"key":"14707_CR55","doi-asserted-by":"crossref","unstructured":"Rein\u00e9s, J. B. et al. Epidemiology of transthyretin-associated Familial amyloid polyneuropathy in the Majorcan area: son Ll\u00e0tzer hospital descriptive study. Orphanet J. Rare Dis 9, (2014).","DOI":"10.1186\/1750-1172-9-29"},{"key":"14707_CR56","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/mus.26034","volume":"57","author":"HH Schmidt","year":"2018","unstructured":"Schmidt, H. H. et al. Estimating the global prevalence of transthyretin Familial amyloid polyneuropathy. Muscle Nerve. 57, 829 (2018).","journal-title":"Muscle Nerve"},{"key":"14707_CR57","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1159\/000154146","volume":"43","author":"A Sousa","year":"1993","unstructured":"Sousa, A., Anderson, R., Drugge, U., Holmgren, G. & Sandgren, O. Familial amyloidotic polyneuropathy in sweden: geographical distribution, age of onset, and prevalence. Hum. Hered. 43, 288\u2013294 (1993).","journal-title":"Hum. Hered"},{"key":"14707_CR58","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s13023-023-02865-5","volume":"18","author":"E Cisneros-Barroso","year":"2023","unstructured":"Cisneros-Barroso, E. et al. Disease risk estimates in V30M variant transthyretin amyloidosis (A-ATTRv) from Mallorca. Orphanet J. Rare Dis. 18, 255 (2023).","journal-title":"Orphanet J. Rare Dis."},{"key":"14707_CR59","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/s41431-019-0361-1","volume":"2019 276 27","author":"SA Biagini","year":"2019","unstructured":"Biagini, S. A. et al. People from ibiza: an unexpected isolate in the Western mediterranean. Eur. J. Hum. Genet. 2019 276 27, 941\u2013951 (2019).","journal-title":"Eur. J. Hum. Genet."},{"key":"14707_CR60","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1136\/jmg.2003.014803","volume":"41","author":"H Ohmori","year":"2004","unstructured":"Ohmori, H. et al. Common origin of the Val30Met mutation responsible for the amyloidogenic transthyretin type of Familial amyloidotic polyneuropathy. J. Med. Genet. 41, e51\u2013e51 (2004).","journal-title":"J. Med. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14707-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14707-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14707-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T13:06:42Z","timestamp":1757423202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14707-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14707"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-14707-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29773"}}